Effect of Low Versus High Dialysate Sodium Concentration During Hemodialysis on Dialysis Recovery Time
Launched by ALEXANDRIA UNIVERSITY · Jun 10, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how different levels of sodium in the dialysate (the fluid used during hemodialysis) affect how quickly patients recover after their dialysis sessions. Researchers want to find out if using a lower or higher amount of sodium can make a difference in recovery time for patients undergoing hemodialysis, which is a treatment for those with end-stage kidney disease.
To be eligible for this study, participants need to be at least 18 years old and have been on long-term hemodialysis three times a week for more than 90 days. They should be able to read and write and be in good mental health. Unfortunately, those who have certain medical conditions, such as severe dementia or current hospital needs, won't be able to participate. If you join the study, you can expect to provide feedback through surveys about your experiences during dialysis, helping researchers understand the best way to support recovery for patients like you.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients with end-stage renal disease who have been prescribed long term hemodialysis and undergo four-hour HD treatments three times a week for more than 90 days.
- • Patient must be at least 18 years old. They must be able to read and write, as well as be in complete mental health.
- Exclusion Criteria:
- • Inability to complete the surveys due to reading or hearing difficulties, actual instability of clinical condition that necessitate hospitalization, dementia, active malignancy or liver failure.
About Alexandria University
Alexandria University, a leading academic institution in Egypt, is dedicated to advancing medical research and improving healthcare outcomes through innovative clinical trials. With a strong emphasis on collaboration and interdisciplinary approaches, the university leverages its extensive resources and expertise to conduct rigorous studies that address pressing health challenges. By fostering partnerships with healthcare professionals, industry leaders, and regulatory bodies, Alexandria University aims to contribute to the global body of medical knowledge and enhance the quality of patient care through evidence-based findings.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Alexandria, , Egypt
Alexandria, , Egypt
Patients applied
Trial Officials
Mohamed Mamdouh Elsayed, MD
Principal Investigator
lecturer
osama M Refai, MBBCh
Study Chair
resident of Nephrology & Internal Medicine, Alexandria University Hospitals
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials